SEARCH

SEARCH BY CITATION

References

  • Allen, C.D., Ansel, K.M., Low, C., Lesley, R., Tamamura, H., Fujii, N. & Cyster, J.G. (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nature Immunology, 5, 943952.
  • Alvaro, T., Lejeune, M., Salvado, M.T., Bosch, R., Garcia, J.F., Jaen, J., Banham, A.H., Roncador, G., Montalban, C. & Piris, M.A. (2005) Outcome in Hodgkin’s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clinical Cancer Research, 11, 14671473.
  • Alvaro, T., Lejeune, M., Salvado, M.T., Lopez, C., Jaen, J., Bosch, R. & Pons, L.E. (2006) Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. Journal of Clinical Oncology, 24, 53505357.
  • Ansel, K.M., Ngo, V.N., Hyman, P.L., Luther, S.A., Forster, R., Sedgwick, J.D., Browning, J.L., Lipp, M. & Cyster, J.G. (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature, 406, 309314.
  • Ascani, S., Zinzani, P.L., Gherlinzoni, F., Sabattini, E., Briskomatis, A., De Vivo, A., Piccioli, M., Fraternali Orcioni, G., Pieri, F., Goldoni, A., Piccaluga, P.P., Zallocco, D., Burnelli, R., Leoncini, L., Falini, B., Tura, S. & Pileri, S.A. (1997) Peripheral T-cell lymphomas. clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification. Annals of Oncology, 8, 583592.
  • Atayar, C., Van Den Berg, A., Blokzijl, T., Boot, M., Gascoyne, R.D., Visser, L. & Poppema, S. (2007) Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments. Journal of Clinical Pathology, 60, 10921097.
  • Attygalle, A., Al-Jehani, R., Diss, T.C., Munson, P., Liu, H., Du, M.Q., Isaacson, P.G. & Dogan, A. (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood, 99, 627633.
  • Bechtel, D., Kurth, J., Unkel, C. & Kuppers, R. (2005) Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood, 106, 43454350.
  • Blank, C., Gajewski, T.F. & Mackensen, A. (2005) Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunology, Immunotherapy, 54, 307314.
  • Boudova, L., Torlakovic, E., Delabie, J., Reimer, P., Pfistner, B., Wiedenmann, S., Diehl, V., Muller-Hermelink, H.K. & Rudiger, T. (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood, 102, 37533758.
  • Brune, V., Tiacci, E., Pfeil, I., Doring, C., Eckerle, S., Van Noesel, C.J., Klapper, W., Falini, B., Von Heydebreck, A., Metzler, D., Brauninger, A., Hansmann, M.L. & Kuppers, R. (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. The Journal of Experimental Medicine, 205, 22512268.
  • Carbone, A., Manconi, R., Poletti, A. & Volpe, R. (1985) Practical importance of immunostaining paraffin-embedded biopsy samples of small lymphocytic and follicle centre cell lymphomas for S100 protein. Lancet, 2, 617.
  • Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., Zagonel, V. & Pinto, A. (1995a) Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin’s disease cell lines. Blood, 85, 780789.
  • Carbone, A., Gloghini, A., Gruss, H.J. & Pinto, A. (1995b) CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin’s disease. The American Journal of Pathology, 147, 912922.
  • Carbone, A., Gloghini, A., Aldinucci, D., Gattei, V., Dalla-Favera, R. & Gaidano, G. (2002) Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. British Journal of Haematology, 117, 366372.
  • Carbone, A., Gloghini, A. & Dotti, G. (2008) EBV-associated lymphoproliferative disorders: classification and treatment. The Oncologist, 13, 577585.
  • Carreras, J., Lopez-Guillermo, A., Fox, B.C., Colomo, L., Martinez, A., Roncador, G., Montserrat, E., Campo, E. & Banham, A.H. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood, 108, 29572964.
  • Chaganti, S., Bell, A.I., Pastor, N.B., Milner, A.E., Drayson, M., Gordon, J. & Rickinson, A.B. (2005) Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. Blood, 106, 42494252.
  • Chang, K.C., Huang, X., Medeiros, L.J. & Jones, D. (2003) Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. The Journal of Pathology, 201, 404412.
  • Chetaille, B., Bertucci, F., Finetti, P., Esterni, B., Stamatoullas, A., Picquenot, J.M., Copin, M.C., Morschhauser, F., Casasnovas, O., Petrella, T., Molina, T., Vekhoff, A., Feugier, P., Bouabdallah, R., Birnbaum, D., Olive, D. & Xerri, L. (2008) Molecular profiling of classical Hodgkin’s lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood, doi:DOI: 10.1182/blood-2008-07-168096
  • Dave, S.S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R.D., Chan, W.C., Fisher, R.I., Braziel, R.M., Rimsza, L.M., Grogan, T.M., Miller, T.P., LeBlanc, M., Greiner, T.C., Weisenburger, D.D., Lynch, J.C., Vose, J., Armitage, J.O., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Connors, J.M., Lansdorp, P.M., Ouyang, Q., Lister, T.A., Davies, A.J., Norton, A.J., Muller-Hermelink, H.K., Ott, G., Campo, E., Montserrat, E., Wilson, W.H., Jaffe, E.S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L.M. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. The New England Journal of Medicine, 351, 21592169.
  • De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Macello, M.R., Aldinucci, D., Pinto, A. & Normanno, N. (2008) The role of the EGFR signaling in tumor microenvironment. Journal of Cellular Physiology, 214, 559567.
  • Diepstra, A., Van Imhoff, G.W., Karim-Kos, H.E., Van Den Berg, A., Te Meerman, G.J., Niens, M., Nolte, I.M., Bastiaannet, E., Schaapveld, M., Vellenga, E. & Poppema, S. (2007) HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin’s lymphoma. Journal of Clinical Oncology, 25, 31013108.
  • Dogan, A., Gaulard, P., Jaffe, E.S., Ralfkiaer, E. & Müller-Hermelink, H.K. (2008) Angioimmunoblastic T-cell lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H.Swerdlow, E.Campo, N.L.Harris, E.S.Jaffe, S.A.Pileri, H.Stein, J.Thiele & J.W.Vardiman), pp. 309311. IARC, Lyon.
  • Dorfman, D.M., Brown, J.A., Shahsafaei, A. & Freeman, G.J. (2006) Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. The American Journal of Surgical Pathology, 30, 802810.
  • Doussis-Anagnostopoulou, I.A., Vassilakopoulos, T.P., Thymara, I., Korkolopoulou, P., Angelopoulou, M.K., Siakantaris, M.P., Kokoris, S.I., Dimitriadou, E.M., Kalpadakis, C., Matzouranis, M., Kaklamanis, L., Panayiotidis, P., Kyrtsonis, M.C., Androulaki, A., Patsouris, E., Kittas, C. & Pangalis, G.A. (2008) Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin’s lymphoma. Clinical Cancer Research, 14, 17591766.
  • Dunleavy, K., Wilson, W.H. & Jaffe, E.S. (2007) Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Current Opinion in Hematology, 14, 348353.
  • Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.C., Haioun, C., Delfau-Larue, M.H. & Gaulard, P. (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. The American Journal of Surgical Pathology, 30, 490494.
  • Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali-Tanci, L., Ugolini, B., Sebastiani, C., Cattoretti, G., Pileri, S., Dalla-Favera, R. & Stein, H. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood, 95, 20842092.
  • Farinha, P., Masoudi, H., Skinnider, B.F., Shumansky, K., Spinelli, J.J., Gill, K., Klasa, R., Voss, N., Connors, J.M. & Gascoyne, R.D. (2005) Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 106, 21692174.
  • Gloghini, A. & Carbone, A. (1993) The nonlymphoid microenvironment of reactive follicles and lymphomas of follicular origin as defined by immunohistology on paraffin-embedded tissues. Human Pathology, 24, 6776.
  • Gloghini, A., Volpe, R. & Carbone, A. (1990) Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid follicles. Human Pathology, 21, 792798.
  • Han, S., Zheng, B., Takahashi, Y. & Kelsoe, G. (1997) Distinctive characteristics of germinal center B cells. Seminars in Immunology, 9, 255260.
  • Harris, N.L., Swerdlow, S.H., Jaffe, E.S. & Ott, G. (2008) Follicular lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H.Swerdlow, E.Campo, N.L.Harris, E.S.Jaffe, S.A.Pileri, H.Stein, J.Thiele & J.W.Vardiman), pp. 220226. IARC, Lyon.
  • Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D.B., Lau, J.S., Zhu, G., Tamada, K. & Chen, L. (2005) Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Research, 65, 10891096.
  • Hollowood, K. & Goodlad, J.R. (1998) Germinal centre cell kinetics. The Journal of Pathology, 185, 229233.
  • Husson, H., Freedman, A.S., Cardoso, A.A., Schultze, J., Munoz, O., Strola, G., Kutok, J., Carideo, E.G., De Beaumont, R., Caligaris-Cappio, F. & Ghia, P. (2002) CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. British Journal of Haematology, 119, 492495.
  • Iwai, Y., Terawaki, S. & Honjo, T. (2005) PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. International Immunology, 17, 133144.
  • Jaffe, E.S. (1995) Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains. Annals of Oncology, 6, 631632.
  • Jaffe, E.S. (2006) Pathobiology of peripheral T-cell lymphomas. Hematology American Society of Hematology Education Program, 2006, 317322.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Isaacson, P.G. (2008) Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood, 112, 43844399.
  • Johnson, P.W., Watt, S.M., Betts, D.R., Davies, D., Jordan, S., Norton, A.J. & Lister, T.A. (1993) Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood, 82, 18481857.
  • Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Kutok, J.L., Rabinovich, G.A. & Shipp, M.A. (2007) The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 104, 1313413139.
  • Khalidi, H.S., Lones, M.A., Zhou, Y., Weiss, L.M. & Medeiros, L.J. (1997) Detection of Epstein-Barr virus in the L & H cells of nodular lymphocyte predominance Hodgkin’s disease: report of a case documented by immunohistochemical, in situ hybridization, and polymerase chain reaction methods. American Journal of Clinical Pathology, 108, 687692.
  • Klein, U. & Dalla-Favera, R. (2008) Germinal centres: role in B-cell physiology and malignancy. Nature Reviews Immunology, 8, 2233.
  • Kraus, M.D. & Haley, J. (2000) Lymphocyte predominance Hodgkin’s disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis. The American Journal of Surgical Pathology, 24, 10681078.
  • Kuppers, R. (2009) The biology of Hodgkin’s lymphoma. Nature Reviews Cancer, 9, 1527.
  • Lee, A.M., Clear, A.J., Calaminici, M., Davies, A.J., Jordan, S., MacDougall, F., Matthews, J., Norton, A.J., Gribben, J.G., Lister, T.A. & Goff, L.K. (2006) Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. Journal of Clinical Oncology, 24, 50525059.
  • Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., Vose, J., Bast, M., Fu, K., Weisenburger, D.D., Greiner, T.C., Armitage, J.O., Kyle, A., May, L., Gascoyne, R.D., Connors, J.M., Troen, G., Holte, H., Kvaloy, S., Dierickx, D., Verhoef, G., Delabie, J., Smeland, E.B., Jares, P., Martinez, A., Lopez-Guillermo, A., Montserrat, E., Campo, E., Braziel, R.M., Miller, T.P., Rimsza, L.M., Cook, J.R., Pohlman, B., Sweetenham, J., Tubbs, R.R., Fisher, R.I., Hartmann, E., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Wrench, D., Lister, T.A., Jaffe, E.S., Wilson, W.H., Chan, W.C. & Staudt, L.M. (2008) Stromal gene signatures in large-B-cell lymphomas. New England Journal of Medicine, 359, 23132323.
  • De Leval, L., Rickman, D.S., Thielen, C., Reynies, A., Huang, Y.L., Delsol, G., Lamant, L., Leroy, K., Briere, J., Molina, T., Berger, F., Gisselbrecht, C., Xerri, L. & Gaulard, P. (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood, 109, 49524963.
  • Lossos, I.S. (2007) The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression. Cancer Cell, 12, 189191.
  • Lossos, I.S. & Levy, R. (2003) Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Seminars in Cancer Biology, 13, 191202.
  • MacLennan, I.C. (1994) Germinal centers. Annual Review of Immunology, 12, 117139.
  • Mancao, C., Altmann, M., Jungnickel, B. & Hammerschmidt, W. (2005) Rescue of ‘crippled’ germinal center B cells from apoptosis by Epstein-Barr virus. Blood, 106, 43394344.
  • Manconi, R., Poletti, A., Volpe, R., Sulfaro, S. & Carbone, A. (1988) Dendritic reticulum cell pattern as a microenvironmental indicator for a distinct origin of lymphoma of follicular mantle cells. British Journal of Haematology, 68, 213218.
  • Marshall, N.A., Christie, L.E., Munro, L.R., Culligan, D.J., Johnston, P.W., Barker, R.N. & Vickers, M.A. (2004) Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood, 103, 17551762.
  • Martinez, A., Pittaluga, S., Rudelius, M., Davies-Hill, T., Sebasigari, D., Fountaine, T.J., Hewitt, S., Jaffe, E.S. & Raffeld, M. (2008) Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. American Journal of Surgical Pathology, 32, 11901200.
  • Nam-Cha, S.H., Roncador, G., Sanchez-Verde, L., Montes-Moreno, S., Acevedo, A., Dominguez-Franjo, P. & Piris, M.A. (2008) PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. The American Journal of Surgical Pathology, 32, 12521257.
  • Natkunam, Y. (2007) The biology of the germinal center. Hematology American Society of Hematology Education Program, 2007, 210215.
  • Natkunam, Y., Hsi, E.D., Aoun, P., Zhao, S., Elson, P., Pohlman, B., Naushad, H., Bast, M., Levy, R. & Lossos, I.S. (2007) Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. Blood, 109, 298305.
  • Nichols, K.E., Hom, J., Gong, S.Y., Ganguly, A., Ma, C.S., Cannons, J.L., Tangye, S.G., Schwartzberg, P.L., Koretzky, G.A. & Stein, P.L. (2005) Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Medicine, 11, 340345.
  • Parolini, O., Weinhausel, A., Kagerbauer, B., Sassmann, J., Holter, W., Gadner, H., Haas, O.A. & Knapp, W. (2003) Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription. Immunogenetics, 55, 116121.
  • Piccaluga, P.P., Agostinelli, C., Califano, A., Carbone, A., Fantoni, L., Ferrari, S., Gazzola, A., Gloghini, A., Righi, S., Rossi, M., Tagliafico, E., Zinzani, P.L., Zupo, S., Baccarani, M. & Pileri, S.A. (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Research, 67, 1070310710.
  • Poppema, S. (1989) The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin’s disease. The American Journal of Pathology, 135, 351357.
  • Poppema, S., Delsol, G., Pileri, S.A. & Stein, H. (2008) Nodular lymphocyte predominant Hodgkin lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H.Swerdlow, E.Campo, N.L.Harris, E.S.Jaffe, S.A.Pileri, H.Stein, J.Thiele & J.W.Vardiman), pp. 323325. IARC, Lyon.
  • Pound, J.D., Challa, A., Holder, M.J., Armitage, R.J., Dower, S.K., Fanslow, W.C., Kikutani, H., Paulie, S., Gregory, C.D. & Gordon, J. (1999) Minimal cross-linking and epitope requirements for CD40 dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. International Immunology, 11, 1120.
  • Quintanilla-Martinez, L., Fend, F., Moguel, L.R., Spilove, L., Beaty, M.W., Kingma, D.W., Raffeld, M. & Jaffe, E.S. (1999) Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. The American Journal of Surgical Pathology, 23, 12331240.
  • Riley, J.L. & June, C.H. (2005) The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood, 105, 1321.
  • Roncador, G., Garcia Verdes-Montenegro, J.F., Tedoldi, S., Paterson, J.C., Klapper, W., Ballabio, E., Maestre, L., Pileri, S., Hansmann, M.L., Piris, M.A., Mason, D.Y. & Marafioti, T. (2007) Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica, 92, 10591066.
  • Schmitter, D., Koss, M., Niederer, E., Stahel, R.A. & Pichert, G. (1997) T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematological Oncology, 15, 197207.
  • Siegert, W., Nerl, C., Agthe, A., Engelhard, M., Brittinger, G., Tiemann, M., Lennert, K. & Huhn, D. (1995) Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. the kiel lymphoma study group. Annals of Oncology, 6, 659664.
  • Stein, H., Delsol, G., Pileri, S.A., Weiss, L.M., Poppema, S. & Jaffe, E.S. (2008) Classical Hodgkin lymphoma, introduction. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H.Swerdlow, E.Campo, N.L.Harris, E.S.Jaffe, S.A.Pileri, H.Stein, J.Thiele & J.W.Vardiman), pp. 326329. IARC, Lyon.
  • Sup, S.J., Alemany, C.A., Pohlman, B., Elson, P., Malhi, S., Thakkar, S., Steinle, R. & Hsi, E.D. (2005) Expression of bcl-2 in classical Hodgkin’s lymphoma: an independent predictor of poor outcome. Journal of Clinical Oncology, 23, 37733779.
  • Teichmann, M., Meyer, B., Beck, A. & Niedobitek, G. (2005) Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma. The Journal of Pathology, 206, 6875.
  • Thorbecke, G.J., Amin, A.R. & Tsiagbe, V.K. (1994) Biology of germinal centers in lymphoid tissue. The FASEB Journal, 8, 832840.
  • Timens, W., Visser, L. & Poppema, S. (1986) Nodular lymphocyte predominance type of Hodgkin’s disease is a germinal center lymphoma. Laboratory Investigation, 54, 457461.
  • Vermi, W., Lonardi, S., Bosisio, D., Uguccioni, M., Danelon, G., Pileri, S., Fletcher, C., Sozzani, S., Zorzi, F., Arrigoni, G., Doglioni, C., Ponzoni, M. & Facchetti, F. (2008) Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. The Journal of Pathology, 216, 356364.
  • Wang, H. & Morse, III, H.C. (2008) IRF8 regulates myeloid and B lymphoid lineage diversification. Immunologic Research, doi: DOI: 10.1007/s12026-008-8055-8
  • Wang, H., Lee, C.H., Qi, C., Tailor, P., Feng, J., Abbasi, S., Atsumi, T. & Morse, III, H.C. (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood, 112, 40284038.
  • Weiss, L.M., Jaffe, E.S., Liu, X.F., Chen, Y.Y., Shibata, D. & Medeiros, L.J. (1992) Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79, 17891795.
  • Went, P., Agostinelli, C., Gallamini, A., Piccaluga, P.P., Ascani, S., Sabattini, E., Bacci, F., Falini, B., Motta, T., Paulli, M., Artusi, T., Piccioli, M., Zinzani, P.L. & Pileri, S.A. (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. Journal of Clinical Oncology, 24, 24722479.
  • Xerri, L., Chetaille, B., Seriari, N., Attias, C., Guillaume, Y., Arnoulet, C. & Olive, D. (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Human Pathology, 39, 10501058.
  • Yamamoto, R., Nishikori, M., Kitawaki, T., Sakai, T., Hishizawa, M., Tashima, M., Kondo, T., Ohmori, K., Kurata, M., Hayashi, T. & Uchiyama, T. (2008) PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood, 111, 32203224.